| Price | 525.00p on 28-07-2026 at 18:35:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 550.00p |
| Sell | 500.00p |
| Last Trade: | Sell 18.00 at 519.75p |
| Day's Volume: | 18 |
| Last Close: | 525.00p |
| Open: | 525.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 525.00p - 525.00p |
| 52wk Range: | 425.00p - 1,000.00p |
| Market Capitalisation: | £81.30m |
| VWAP: | 519.75p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 18 | 519.75p | Ordinary |
15:02:30 - 28-Jul-26 |
| Sell* | 1 | 510.00p | Ordinary |
09:40:57 - 27-Jul-26 |
| Sell* | 3 | 500.00p | SI Trade |
09:18:19 - 27-Jul-26 |
| Sell* | 2 | 500.00p | SI Trade |
09:18:19 - 27-Jul-26 |
| Unknown* | 0 | 500.00p | SI Trade |
09:18:19 - 27-Jul-26 |
| Sell* | 19 | 519.75p | Ordinary |
08:30:26 - 27-Jul-26 |
| Sell* | 3 | 502.50p | Ordinary |
08:00:22 - 27-Jul-26 |
| Sell* | 8 | 519.75p | Ordinary |
15:53:01 - 24-Jul-26 |
| Sell* | 1 | 500.50p | Ordinary |
13:06:32 - 24-Jul-26 |
| Sell* | 143 | 502.50p | Ordinary |
15:58:51 - 23-Jul-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Jul 2026 7:00 am | PRN | Grant of Options & Director/PDMR Dealing |
| 8th Jul 2026 7:00 am | PRN | Director Appointment |
| 30th Jun 2026 5:37 pm | PRN | Result of AGM & Issue of Options |
| 16th Jun 2026 7:00 am | PRN | Notice of Investor Presentation |
| 15th Jun 2026 7:00 am | PRN | 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board |
| 5th Jun 2026 7:00 am | PRN | Notice of Annual General Meeting |
| 22nd May 2026 9:10 am | PRN | Director Dealing |
| 20th May 2026 7:02 am | PRN | Final Results and Notice of AGM |
| 20th May 2026 7:00 am | PRN | 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial |
| 14th May 2026 7:00 am | PRN | Appointment of Chief Financial Officer and Board Changes |